Skip to main content
SpringerLink
Log in

Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: A population based study

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Background: Current reference values for thyroid function tests are based on data from different ethnicities and geographical areas. The aim of the present study was to determine reference intervals for thyrotropin (TSH) and free T4 (FT4), based on the criteria of the National Academy of Clinical Biochemistry (NACB) in an Iranian population. Material and methods: This study was conducted within the framework of Tehran Thyroid Study (TTS), an ongoing prospective cohort of 5704 randomly selected individuals, age ≥20 yr. A total of 2199 individuals (43.3% male, 56.7% female), based on NACB criteria were included in this study. Reference limit analysis was performed for the negative thyroid peroxidase antibody (TPOAb) group. Results: After applying all exclusion criteria except TPOAb positivity (10.5%), data of 2459 participants remained for analysis. Of these, 953 (43.3%) were males and 1246 (56.7%) were females; the mean±SD age was 43.53±14.16 yr. The mean±SD and median+IQR for TSH were 1.77 mU/l ±1.24 and 1.46 (0.93–2.23) mU/l, respectively. The 2.5th and 97.5th percentiles TSH were 0.32 mU/l and 5.06 mU/l respectively. The mean±SD and median (IQR) for FT4 for all negative TPOAb subjects were 1.19±0.16 and 1.18 (1.08–1.31) ng/dl respectively. Conclusion: Reference ranges for thyroid function tests need to be derived from national databases. This study determined age and sex specific TSH and FT4 reference ranges in a Tehranian population, which could eventually enable clinicians to classify patients more appropriately.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Kronenberg HM, Williams RH. Thyroid physiology and diagnostic evaluation of patients with thyroid. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR eds. Williams Textbook of Endocrinology, 11th ed. Philadelphia: Saunders, 2008, 312–3.

    Google Scholar 

  2. Demers LM, Spencer CA. Laboratory support for the diagnosis and monitoring of thyroid disease. Clin Endocrinol 2003, 53: 138–40.

    Article  Google Scholar 

  3. Klee GG, Hay ID. Biochemical testing of thyroid function. Endocrinol Metab Clin North Am 1997, 26: 763–75.

    Article  PubMed  Google Scholar 

  4. Baloch Z, Carayon P, Conte-Devoix B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13: 3–126.

    Article  PubMed  Google Scholar 

  5. Kratzsch J, Fielder GM, Leichtle A, et al. New reference intervals for thyrotropin and thyroid hormones based on National Academy of Clinical Biochemistry criteria and regular ultrasonography of the thyroid. Clin Chem 2005, 51: 1480–6.

    Article  PubMed  Google Scholar 

  6. Volzke H, Alte D, Kohlmann T, et al. Reference intervals of serum thyroid function tests in a previously iodine-deficient area. Thyroid 2005, 15: 279–85.

    Article  PubMed  Google Scholar 

  7. Hoogendoorn EH, Hermus AR, de Vegt F, et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influence of age and sex. Clin Chem 2006, 52: 104–11.

    Article  PubMed  Google Scholar 

  8. Hamilton TE, Davis S, Onstad L, et al. Thyrotropin levels in a population with no clinical, autoantibody, or ultrasonographic evidence of thyroid disease: implications for the diagnosis of subclinical hypothyroidism. J Clin Endocrinol Metab 2008, 93: 1224–30.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Jensen E, Hyltoft Petersen P, Blaabjerg O, et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin Chem Lab Med 2004, 42: 824–32.

    Article  PubMed  Google Scholar 

  10. Lee YK, Kim JE, Oh HJ, et al. Serum TSH level in healthy Koreans and the association of TSH with serum lipid concentration and metabolic syndrome. Korean J Intern Med 2011, 26: 432–9.

    Article  PubMed Central  PubMed  Google Scholar 

  11. Yoshihara A, Noh JY, Ohye H, et al. Reference limits for serum thyrotropin in a Japanese population. Endocr J 2011, 58: 585–8.

    Article  PubMed  Google Scholar 

  12. Schalin-Jäntti C, Tanner P, Välimäki MJ, Hämäläinen E. Serum TSH reference interval in healthy Finnish adults using the Abbott Architect 2000i Analyzer. Scand J Clin Lab Invest 2011, 71: 344–9.

    Article  PubMed  Google Scholar 

  13. Chan AO, Iu YP, Shek CC. The reference interval of thyroid-stimulating hormone in Hong Kong Chinese. J Clin Pathol 2011, 64: 433–6.

    Article  PubMed  Google Scholar 

  14. Meyerovitch J, Rotman-Pikielny P, Sherf M, et al. Serum thyrotropin measurements in the community: five-year fol low-up in a large network of primary care physicians. Arch Intern Med 2007, 167: 1533–8.

    Article  PubMed  Google Scholar 

  15. Baskin HJ, Cobin RH, Duick DS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism. Endocr Pract 2002, 8: 457–69.

    PubMed  Google Scholar 

  16. Stathatos N, Wartofsky L. Managing subclinical hypothyroidism in women. Women Health Primary Care 2002, 5: 239–46.

    Google Scholar 

  17. Wartofsky L, Dickey RA. Controversy in clinical endocrinology: the evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005, 90: 5483–8.

    Article  PubMed  Google Scholar 

  18. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T4, and thyroid antibodies in the United State population (1988–1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87: 489–99.

    Article  PubMed  Google Scholar 

  19. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over the age 55 years. A study in an urban US community. Arch Intern Med 1990, 150: 785–7.

    Article  PubMed  Google Scholar 

  20. Atzmon G, Barzilai N, Hollowell JG, Surks MI, Gabriely I. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009, 94: 1251–4.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012, 97: 1554–62.

    Article  PubMed  Google Scholar 

  22. Schectman JM, Kallenberg GA, Hirsch RP, Shumacher RJ. Report of an association between race and thyroid stimulating hormone level. Am J Public Health 1991, 81: 505–6.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol 2009, 70: 788–93.

    Article  Google Scholar 

  24. Boucai L, Hollowell JG, Surks MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011, 21: 5–11.

    Article  PubMed Central  PubMed  Google Scholar 

  25. Li C, Guan H, Teng X, et al. An epidemiological study of the serum thyrotropin reference range and factors that influence serum thyrotropin levels in iodine sufficient areas of China. Endocr J 2011, 58: 995–1002.

    Article  PubMed  Google Scholar 

  26. Delshad H, Amouzegar A, Mirmiran P, Mehran L, Azizi F. Eighteen years of continuously sustained elimination of iodine deficiency in the Islamic Republic of Iran: the vitality of periodic monitoring. Thyroid 2012, 22: 415–21.

    Article  PubMed  Google Scholar 

  27. Eskelinen S, Suominen P, Vahlberg T, et al. The effect of thyroid antibody positivity on reference intervals for thyroid stimulating hormone (TSH) and free thyroxine (FT4) in an aged population. Clin Chem Lab Med 2005, 43: 1380–5.

    Article  PubMed  Google Scholar 

  28. Tunbridge WMG, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham Survey. Clin Endocrinol 1977, 7: 481–93.

    Article  Google Scholar 

  29. Surks MI, Hollowell JG. Age-specific distribution of serum TSH and antithyroid antibodies in the United States population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92: 4575–82.

    Article  PubMed  Google Scholar 

  30. Tanda ML, Piantanida E, Lai A, et al. Thyroid autoimmunity and environment. Horm Metab Res 2009, 41: 436–42.

    Article  PubMed  Google Scholar 

  31. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 2000, 10: 251–9.

    Article  PubMed  Google Scholar 

  32. Vejbjerg P, Knudsen N, Perrild H, et al. The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population. Eur J Endocrinol 2006, 155: 547–52.

    Article  PubMed  Google Scholar 

  33. Bryhni B, Aanderud S, Sundsfjord J, Rekvig OP, Jorde R. Thyroid antibodies in northern Norway: prevalence, persistence and relevance. J Intern Med 1996, 239: 517–23.

    Article  PubMed  Google Scholar 

  34. Pedersen IB, Knudsen N, Jørgensen T, Perrild H, Ovesen L, Laurberg P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin Endocrinol (Oxf) 2003, 58: 36–42.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Endocrine Research Centre, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran

    A. Amouzegar, H. Delshad, L. Mehran, F. Khafaji & F. Azizi MD

  2. Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran

    M. Tohidi

Authors
  1. A. Amouzegar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Delshad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. Mehran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Tohidi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Khafaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Azizi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F. Azizi MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Amouzegar, A., Delshad, H., Mehran, L. et al. Reference limit of thyrotropin (TSH) and free thyroxine (FT4) in thyroperoxidase positive and negative subjects: A population based study. J Endocrinol Invest 36, 950–954 (2013). https://doi.org/10.3275/9033

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.3275/9033

Key-words

Search

Navigation